Search
for
Sort by
Research 121–150 of 305
- Women with clinically significant hirsutism always have detectable endocrinological abnormalities
- Revisiting hyper- and hypo-androgenism by tandem mass spectrometry
- Activation of nuclear factor κB in response to cream ingestion is related to ovarian androgen hypersecretion in polycystic ovary syndrome
- Urinary 5-ene-steroid excretion in non-classical congenital adrenal hyperplasia due to 3β-hydroxysteroid dehydrogenase deficiency (NC-3BHSD)
- Steroidogenesis in steroid related cancers
- The influence of non-esterified fatty acids (NEFA) on the ovarian production of androgens in a context of in vitro fertilisation (IVF) – preliminary results
- Polycystic ovary syndrome: etiology, pathogenesis and diagnosis
- American Association of Clinical Endocrinologists, American College of Endocrinology, and Androgen Excess and PCOS Society Disease State Clinical Review: Guide to the Best Practices in the Evaluation and Treatment of Polycystic Ovary Syndrome - Part 1
- Genetic, hormonal and metabolic aspects of PCOS: an update
- The prevalence of polycystic ovary syndrome in a normal population according to the Rotterdam criteria versus revised criteria including anti-Mullerian hormone
- A Prospective Study of the Prevalence of Nonclassical Congenital Adrenal Hyperplasia among Women Presenting with Hyperandrogenic Symptoms and Signs
- Clinical and endocrine characteristics of the main polycystic ovary syndrome phenotypes
- The pathophysiology of polycystic ovary syndrome: trying to understand PCOS and its endocrinology
- Adult polycystic ovary syndrome begins in childhood
- Androgen Dependence of Hirsutism, Acne, and Alopecia in Women
- Polycystic Ovarian Syndrome
- Polycystic Ovary Syndrome
- <i>Polycystic Ovary Syndrome in Adolescence</i>
- Insulin sensitiser agents alone and in co-treatment with r-FSH for ovulation induction in PCOS women
- MENSTRUAL DISORDERS IN ADOLESCENTS
- Permanent scalp alopecia related to breast cancer chemotherapy by sequential fluorouracil/epirubicin/cyclophosphamide (FEC) and docetaxel: a prospective study of 20 patients
- How should postmenopausal androgen excess be evaluated?
- Androgens in women
- Nonclassic Congenital Adrenal Hyperplasia
- Androgen receptor gene CAG repeat polymorphism in women with polycystic ovary syndrome
- Insulin resistance and obesity among infertile women with different polycystic ovary syndrome phenotypes
- Polycystic Ovary Syndrome and Its Differential Diagnosis
- Evidence for Increased 5α-Reductase Activity During Early Childhood in Daughters of Women With Polycystic Ovary Syndrome
- Prevalence of CYP21 mutations and IRS1 variant among women with polycystic ovary syndrome and adrenal androgen excess
- ANTIANDROGEN THERAPY IN DERMATOLOGY